4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0000899243-21-045310
Chief Executive Officer acquired 600,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schuetz Thomas J. Chief Executive Officer | 2021-11-16 | Grant or award | +600,000 | 5,125,467 | D |
Loading xslF345X03/doc4.xml…